Vanderbilt Ingram Cancer Center

Several investigators in Vanderbilt-Ingram Cancer Center’s (VICC) Breast Cancer Program have received grant awards to support translational research that may improve disease outcomes for patients. Read More

The Vanderbilt-Ingram Cancer Center (VICC) announces a funding opportunity to catalyze innovative, collaborative ovarian cancer-related projects. Read More

Vanderbilt researchers hope their new method to describe cells will be widely adopted and used to generate a “Who’s Who” database of cell types. Read More

Country music artist and cancer survivor Wade Hayes will host the second annual “Country Hits Back” benefit concert March 7 at the Franklin Theatre. The event will support vitally important cancer research at Vanderbilt-Ingram Cancer Center. Read More

Douglas Lowy, M.D., acting director of the National Cancer Institute (NCI), warned that worldwide death rates from cervical cancer are expected to increase in low- and middle-income countries during the next 15 years unless steps are taken to prevent the cancer from occurring. Almost all cases of cervical cancer are linked to a viral infection. Read More

Cancer patient Sharon Edwards will lift her voice toward what she hopes is a better year when she sings for Pope Francis later this month. Read More

Vanderbilt-Ingram Cancer Center (VICC) has joined an international consortium of leading cancer centers to share genomic data from patients in an effort to accelerate the pace of cancer research and improve precision medicine. Read More

Metastatic pancreatic cancer — cancer that has spread from the pancreas to other tissues and is responsible for most patient deaths — changes its metabolism and is “reprogrammed” for optimal malignancy, according to new findings reported Jan. 16 in Nature Genetics. Read More

Nearly 39,000 new cancers associated with the human papillomavirus (HPV) will be diagnosed in the United States this year. Although HPV vaccines can prevent the majority of these cancers, vaccination rates remain low across the country. Read More

Colleen Morton, M.D., has joined Vanderbilt University Medical Center (VUMC) as section chief of Classical Hematology, a specialty also known as “benign hematology” because it covers all blood disorders that are not cancer. Read More

Researchers in the Schools of Medicine and Engineering at Vanderbilt University have discovered a proteomic “signature” from the airways of heavy smokers that could lead to better risk assessment and perhaps new ways to stop lung cancer before it starts. Read More

Douglas R. Lowy, acting director of the National Cancer Institute, will deliver the Vanderbilt-Ingram Cancer Center George Daniel Brooks Lecture at Vanderbilt University Medical Center on Tuesday, Jan. 24, at 11 a.m. in Light Hall, Room 208. The title of the presentation is “Preventing HPV-associated Cancers: Short-term and Long-term Approaches.” Read More

Vanderbilt investigators recommend that the presence of tumor deposits in the abdomen be included when staging midgut neuroendocrine tumors. Read More

Finn Schafran has always been a happy child, but these days the nearly 2-year-old boy is adjusting to spending part of each day at Vanderbilt-Ingram Cancer Center (VICC), where he receives chemotherapy and radiation for a rare cancer. Read More

Harold (Hal) Moses, M.D., Ingram Professor of Cancer Research and director emeritus of Vanderbilt-Ingram Cancer Center (VICC), has been named a Fellow of the National Academy of Inventors (NAI). Moses, professor and interim chair of Cancer Biology, is among 175 academic leaders named to the 2016 class of NAI Fellows. Read More

Nashville entrepreneur-turned-artist Cano Ozgener and his family have repeatedly faced cancer and its consequences, but rather than feel embattled, they've chosen to respond by creating beauty to share with others and by actively supporting the mission of the Vanderbilt-Ingram Cancer Center (VICC). Read More

Members of the Vanderbilt community are mourning the loss of music executive and health care philanthropist Tony Martell, who died Sunday, Nov. 27, at his home in New Jersey. He was 90. Read More

Forward is the only direction in which Anna Rodriguez likes to travel. Read More

Two Vanderbilt-Ingram Cancer Center (VICC) investigators have earned grant awards from The V Foundation for Cancer Research, continuing the foundation’s support for innovative cancer research initiatives at VICC. Read More

Personalized medicine is about tailoring treatment to individual patients based on their genetics. Georgia L. Wiesner, director of the Vanderbilt-Ingram Cancer Center’s Clinical and Translational Hereditary Cancer Program, explains the “4 Ps” of personalized medicine and the benefits it offers. Read More